JP2007509184A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007509184A5 JP2007509184A5 JP2006537162A JP2006537162A JP2007509184A5 JP 2007509184 A5 JP2007509184 A5 JP 2007509184A5 JP 2006537162 A JP2006537162 A JP 2006537162A JP 2006537162 A JP2006537162 A JP 2006537162A JP 2007509184 A5 JP2007509184 A5 JP 2007509184A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- hydrogen
- alkyl
- formula
- indol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229910052739 hydrogen Inorganic materials 0.000 claims description 19
- 239000001257 hydrogen Substances 0.000 claims description 19
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 16
- 150000001875 compounds Chemical class 0.000 claims description 9
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 9
- 229910052736 halogen Inorganic materials 0.000 claims description 6
- 150000002367 halogens Chemical class 0.000 claims description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 6
- 125000001424 substituent group Chemical group 0.000 claims description 6
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 6
- 125000000814 indol-3-yl group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C([*])C2=C1[H] 0.000 claims description 5
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims description 2
- 206010046543 Urinary incontinence Diseases 0.000 claims description 2
- 150000002431 hydrogen Chemical class 0.000 claims description 2
- 125000001624 naphthyl group Chemical group 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- -1 3,5-bistrifluoromethyl-phenyl Chemical group 0.000 claims 7
- 239000000203 mixture Substances 0.000 claims 6
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 claims 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 3
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 2
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims 2
- 125000004361 3,4,5-trifluorophenyl group Chemical group [H]C1=C(F)C(F)=C(F)C([H])=C1* 0.000 claims 1
- 125000005809 3,4,5-trimethoxyphenyl group Chemical group [H]C1=C(OC([H])([H])[H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 claims 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 125000005059 halophenyl group Chemical group 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51479103P | 2003-10-27 | 2003-10-27 | |
| PCT/EP2004/012081 WO2005039563A2 (en) | 2003-10-27 | 2004-10-26 | Use of neurokinin antagonists in the treatment of urinary incontinence |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007509184A JP2007509184A (ja) | 2007-04-12 |
| JP2007509184A5 true JP2007509184A5 (enExample) | 2007-12-06 |
Family
ID=34520229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006537162A Pending JP2007509184A (ja) | 2003-10-27 | 2004-10-26 | 尿失禁の処置におけるニューロキニンアンタゴニストの使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7776851B2 (enExample) |
| EP (2) | EP2158910A1 (enExample) |
| JP (1) | JP2007509184A (enExample) |
| CN (1) | CN1874766A (enExample) |
| AU (1) | AU2004283038B9 (enExample) |
| BR (1) | BRPI0415923A (enExample) |
| CA (1) | CA2543552A1 (enExample) |
| MX (1) | MXPA06004688A (enExample) |
| WO (1) | WO2005039563A2 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1938804A1 (en) * | 2006-12-22 | 2008-07-02 | Novartis AG | Pharmaceutical formulation comprising neurokinin antagonist |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993001169A2 (en) * | 1991-07-05 | 1993-01-21 | Merck Sharp & Dohme Limited | Aromatic compounds, pharmaceutical compositions containing them and their use in therapy |
| FR2700472B1 (fr) * | 1993-01-19 | 1995-02-17 | Rhone Poulenc Rorer Sa | Association synergisante ayant un effet antagoniste des récepteurs NK1 et NK2. |
| MY132550A (en) * | 1996-08-22 | 2007-10-31 | Novartis Ag | Acylaminoalkenylene-amide derivatives as nk1 and nk2 antogonists |
| GB0015246D0 (en) * | 2000-06-22 | 2000-08-16 | Astrazeneca Ab | Method for the treatment of urinary incontinence |
| US6664253B2 (en) * | 2000-10-17 | 2003-12-16 | Boehringer Ingelheim Pharma Kg | Neurokinin antagonists |
| US20040058914A1 (en) * | 2000-12-22 | 2004-03-25 | Takayuki Doi | Combination drugs |
| WO2002072145A1 (en) * | 2001-03-14 | 2002-09-19 | Ono Pharmaceutical Co., Ltd. | Remedies for depression containing ep1 antagonist as the active ingredient |
| BR0307156A (pt) * | 2002-01-18 | 2004-12-07 | Kyorin Seiyaku Kk | Derivado de pirimidina bicìclica fundida, composto, antagonistas de receptores e agentes profiláticos e terapêuticos |
| GB0203061D0 (en) * | 2002-02-08 | 2002-03-27 | Novartis Ag | Organic compounds |
| NZ535183A (en) * | 2002-03-26 | 2006-03-31 | Kyorin Seiyaku Kk | Fused bicyclic pyrimidine derivatives |
| KR20040099367A (ko) * | 2002-03-26 | 2004-11-26 | 교린 세이야꾸 가부시키 가이샤 | 타키키닌 수용체 길항제로서의 축합 바이사이클릭 피리딘 유도체 |
-
2004
- 2004-10-26 BR BRPI0415923-3A patent/BRPI0415923A/pt not_active IP Right Cessation
- 2004-10-26 CN CNA2004800316761A patent/CN1874766A/zh active Pending
- 2004-10-26 EP EP09013092A patent/EP2158910A1/en not_active Withdrawn
- 2004-10-26 JP JP2006537162A patent/JP2007509184A/ja active Pending
- 2004-10-26 CA CA002543552A patent/CA2543552A1/en not_active Abandoned
- 2004-10-26 WO PCT/EP2004/012081 patent/WO2005039563A2/en not_active Ceased
- 2004-10-26 EP EP04790864A patent/EP1686985A2/en not_active Ceased
- 2004-10-26 US US10/576,052 patent/US7776851B2/en not_active Expired - Fee Related
- 2004-10-26 AU AU2004283038A patent/AU2004283038B9/en not_active Ceased
- 2004-10-26 MX MXPA06004688A patent/MXPA06004688A/es active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2005046318A3 (en) | Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of asbestos-related diseases and disorders | |
| EP2210606A3 (en) | Compositions comprising immunomodulatory compounds for the treatment and management of myeloproliferative diseases | |
| JP2013541514A5 (enExample) | ||
| JP2006182786A5 (enExample) | ||
| JP2009504763A5 (enExample) | ||
| WO2005044178A3 (en) | Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain | |
| JP2007519649A5 (enExample) | ||
| JP2008538741A (ja) | 鬱病の治療用及び/又は予防用の医薬組成物 | |
| US7105504B2 (en) | Combination of a CB1 receptor antagonist and of a product which activates dopaminergic neurotransmission in the brain, the pharmaceutical compositions comprising them and their use in the treatment of parkinson's disease | |
| JP2009526821A (ja) | 注意欠陥多動性障害治療用の新規な医薬組成物 | |
| JP2008531714A (ja) | 不安障害の治療用及び/又は予防用の医薬組成物 | |
| JP2004531517A5 (enExample) | ||
| JP2007533722A5 (enExample) | ||
| JP2007508360A5 (enExample) | ||
| WO2005105088A3 (en) | Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of pulmonary hypertension | |
| JP2019515884A5 (enExample) | ||
| WO2018060463A3 (en) | Treatment of prostate cancer | |
| JP2010511631A5 (enExample) | ||
| JP2014505107A5 (enExample) | ||
| JP2017512211A5 (enExample) | ||
| JP2009513713A5 (enExample) | ||
| JP2007500160A5 (enExample) | ||
| JP2006510659A5 (enExample) | ||
| RU2017137008A (ru) | Антагонисты толл-подобного рецептора 4 и применение при аутоиммунных заболеваниях печени | |
| JP2007509184A5 (enExample) |